Philips has received CE marking for its latest SmartCT 3.0 image reconstruction solution, expanding availability across Europe after launches in Japan and Canada. Designed for the Philips Azurion neuro biplane system, SmartCT 3.0 delivers advanced cone-beam CT imaging that provides neurointerventionalists with real-time, high-quality 3D views of brain tissue, blood vessels, and devices directly in the angiography suite. This innovation eliminates the need to move patients to separate CT scanners, significantly speeding up diagnosis and treatment during critical neurovascular procedures such as ischemic stroke interventions.

The system’s sophisticated features—including rapid 8-second soft tissue helical scanning, motion-compensated imaging for restless patients, and dual-phase cerebral visualization—offer clinicians unparalleled clarity and precision. These capabilities help streamline workflows, reduce procedural complexity, and support personalized treatment plans like mechanical thrombectomy, a minimally invasive technique for removing blood clots. The SmartCT Dual Viewer further enhances procedural planning by enabling side-by-side manipulation of two 3D volumes without breaking sterility, allowing physicians to make more informed decisions on the spot.

In stroke care, where every minute counts, SmartCT 3.0 empowers clinicians with faster, more confident insights that can improve patient outcomes and save lives. By integrating cutting-edge imaging directly into the interventional suite, Philips strengthens its commitment to advancing neurovascular care through innovative technology. The CE marking marks a key milestone for SmartCT, ensuring European healthcare providers can access this vital tool in their efforts to reduce delays and optimize stroke treatment pathways.